---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-024760"
form_type: "8-K"
ticker: "AIM"
cik: "0000946644"
company_name: "AIM ImmunoTech Inc."
filed_at: "2026-05-21T15:31:14+00:00"
generated_at: "2026-05-21T15:33:58.587817+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# AIM ImmunoTech prices $2.4M registered direct offering of 7.5M shares and warrants

## Summary
- Offering of 7,519,351 shares at $0.325 per share; gross proceeds ~$2.4M before expenses.
- Concurrent private placement of Common Warrants to purchase up to 15,038,702 shares at $0.325.
- Warrants exercisable after stockholder approval, expire 5 years later; potential additional $4.9M.
- Closing expected May 21, 2026; company expects at least $6M in stockholders' equity post-closing.

## SEC filing metadata
- accession: 0001493152-26-024760
- form_type: 8-K
- ticker: AIM
- cik: 0000946644
- company_name: AIM ImmunoTech Inc.
- filed_at: 2026-05-21T15:31:14+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946644/000149315226024760/0001493152-26-024760-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946644/000149315226024760/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-024760
- JSON: https://secwatch.observer/filing/0001493152-26-024760.json
- Plain text: https://secwatch.observer/filing/0001493152-26-024760.txt

## Key facts
- Material Agreements
  AIM ImmunoTech Inc. entered into Purchase Agreement with institutional investors valued at approximately $2.4 million (effective 2026-05-20).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: institutional investors
  - Value: approximately $2.4 million
  - Effective: 2026-05-20
  source text: On May 20, 2026, AIM ImmunoTech Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with institutional investors (the “Investors”), pursuant to which the Company agreed to issue and sell to such investors in a registered direct offering 7,519,351 shares (the “Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company, at an offering price of $0.325 per share (such registered direct offering, the “Registered Offering”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/946644/000149315226024760/0001493152-26-024760-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.